Elad Gil
15 statements across 1 episodes · 5 bullish · 5 bearish · 1 people on the record · first statement Jan 2, 2019 by Elad Gil · said 1 times in 1 episodes since 2023 · across every show →
On the record as a speaker too: Elad Gil's record, appearances and statements → this page counts the times other people say the name.
Mentions by year
brought up most by Immad Akhund (1)
tap a year for its mentions
2023 1 mention in 1 episode
Everything said about Elad Gil, oldest first
Jan 2, 2019 bullish
Gil: Biopharma's focus on specific diseases creates longevity market opportunity
“Biopharma in general tends to be focused on oncology or cancer and a few other areas. And they're not really thinking about how can I push disease back in general, you know, with a drug. So I do think there's a big market gap, which creates a really interestin…”
Jan 2, 2019 bearish
Jan 2, 2019
Jan 2, 2019 neutral
Gil: Startup success requires cash, co-founder harmony, and product-market fit
“If you think about it, the surface area of an early stage company is actually really simple. It's don't run out of money, don't fight with your co-founder, and find product market fit, and that's all you have to do, and you'll be successful to some extent.”
Jan 2, 2019 bullish
Jan 2, 2019 bearish
Jan 2, 2019
Gil: Early startup employees must accept temporary shrinkage of responsibility
“And the other thing you should expect as an old timer is your role is gonna shrink and then it'll expand. And you need to be okay with that shrinking period. And you need to be okay with you losing responsibility before you suddenly gain tons of responsibility…”
Jan 2, 2019 negative
Jan 2, 2019 bearish
Jan 2, 2019
Jan 2, 2019 bullish
Jan 2, 2019 negative
Gil: Structured late-stage venture deals are debt masquerading as equity
“On the late stages, some companies start building in very complicated structures and because they want that very high valuation, and a firm may be willing to give it, but then they build in extra preference or participation for the investor, or things that eff…”
Jan 2, 2019 bullish
Gil: Biopharma drugs extending human lifespan are a key investment focus
“I'm personally very interested in sort of longevity and anti-aging technologies. And by that, I mean true biopharma, which is translating existing science that's existed in labs for 1020 years, and is trying to turn it into drugs that can extend lifespan prett…”
Jan 2, 2019
Gil: Founders should hire executives for 12 to 18 month horizons
“You should always be thinking of the person as the right person for the next 12 to 18 months, not the person for the next five years, and so I think a common mistake is that people will end up hiring, you know, they'll have a twenty-person engineering team, an…”
Jan 2, 2019 positive
Gil: Rapamycin and metformin extend organism lifespans by 5% to 30%
“There's at least two FDA approved drugs that in multiple organisms will extend lifespan between five and 30%. One of them is rapamycin, which in mice, for example, extend lifespan 10 to 30%, and it also extends lifespan And flies and worms and other organisms.…”